STUDY SEARCH RESULTS

2 studies found for your search request:  0616-017

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults with Heterozygous Familial ...
Condition: Hypercholesterolemia, Familial Hypercholesterolemia
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05952869
Status: Completed
Has Results

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adul...
Condition: Hypercholesterolemia
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06492291
Status: Active, not recruiting




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site